CAPELLE AAN DEN IJSSEL, The Netherlands–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/EURETINA19?src=hash" target="_blank">#EURETINA19</a>–Topcon Europe Medical announces its participation in EURETINA 2019, the…
Uncategorized
Alcon Reports Second Quarter and First Half 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Second Quarter and First Half 2019 Results
Uncategorized
Alcon Reports Second Quarter and First Half 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Second Quarter and First Half 2019 Results
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
Uncategorized
Aerie begins trial of sustained release drug for retinal disease
Aerie Pharmaceuticals has initiated a clinical trial of AR-13503, a sustained release implant, for treatment of neovascular age-related macular degeneration or diabetic macular edema, according to a press release.The implant, which is made of bio-erodi…
Uncategorized
Sutureless dacryocystorhinostomy closure scars less than subcuticular technique
A sutureless wound closure technique led to less scarring and better cosmesis than subcuticular technique in external dacryocystorhinostomy procedures.Fifty patients scheduled for external dacryocystorhinostomy for nasolacrimal duct obstruction were ra…